Havens Advisors Top New Positions: Covidien plc (COV), Idenix Pharmaceuticals Inc. (IDIX) and Others

In its recent 13F filing with the U.S. Securities and Exchange Commission, Nancy Havens-Hasty’s Havens Advisors has disclosed its long equity positions for the second quarter of 2014. The value of the fund’s equity portfolio amounted to $137.9 million, representing an increase from the previous value of $98.1 million. According to the filing, the fund acquired more than 24 new stocks and sold out its holdings in 10 stocks. The fund has a strong focus on Healthcare and Technology stocks. We’ll take a look the top five new positions from the fund’s equity portfolio.

Covidien plc (NYSE:COV)

First on the list is Covidien plc (NYSE:COV), in which Havens Advisors revealed a $9.4 million stake, containing 104,000 shares of the company. Covidien PLC (NYSE:COV) is a global healthcare technology and medical supplies provider that has a market cap of $40.42 billion. Last month, Covidien plc (NYSE:COV) and Medtronic Inc. (NYSE: MDT) announced that they signed a definitive agreement under which Medtronic will acquire Covidien in a cash-and-stock transaction valued at about $42.9 billion. The deal is expected to close in the fourth calendar quarter of 2014 or early 2015. Among the largest shareholders of Covidien plc (NYSE:COV) include First Pacific Advisors LLC, led by Robert Rodriguez and Steven Romick, which owns 5.18 million shares and Harris Associates, which holds 3.69 million shares.

Next holding is Idenix Pharmaceuticals Inc. (NASDAQ:IDIX), which is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Havens Advisors holds 251,000 shares of the company, with a reported value of $6.05 million. During the second week of June, Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) announced a definitive agreement under which Merck (NYSE:MRK) agreed to acquire Idenix for $24.50 per share in cash. The transaction is expected to close in the third quarter of 2014, according to a press release. Aside from Havens Advisors, Seth Klarman’s Baupost Group holds 53.33 million shares, and Brookside Capital owns 9 million shares of the company, according to our record.

In DIRECTV (NASDAQ:DTV), Havens Advisors disclosed owning 59,000 shares, worth $5.02 million. DIRECTV (NASDAQ:DTV) is a provider of digital television entertainment services, having a market cap of $43.80 billion. In May, AT&T (NYSE:T) agreed to acquire DIRECTV (NASDAQ:DTV) in a stock-and-cash transaction for $95 per share. The agreement was approved unanimously by the boards of directors of both companies, and the transaction is expected to close within about 12 months. Other significant shareholders of the company include Warren Buffett’s Berkshire Hathaway, and Harris Associates, holding 34.51 million shares, and 9.14 million shares, respectively.

The fourth-largest holding is represented by Hillshire Brands Co. (NYSE:HSH), in which the fund revealed holding 62,500 shares, with a reported value of $3.89 million. At the beginning of this month, the company entered into a definitive agreement with Tyson Foods Inc. (NYSE: TSN). Under the agreement, Tyson Foods agreed to acquire all outstanding shares of Hillshire Brands for $63 per share, with the all-cash transaction valued at about $8.55 billion, including the company’s outstanding net debt. The deal is anticipated to close by September 27, 2014, according to a news release. In addition to Havens Advisors, Ken Griffin’s Citadel Investment Group holds 4.99 million shares of the company, while Mario Gabelli’s GAMCO Investors disclosed owning 2.70 million shares.

On the fifth position is MICROS Systems Inc. (NASDAQ:MCRS), in which Havens Advisors reported owing 40,000 shares, worth $2.72 million. Last month, Oracle Corporation (NYSE:ORCL) said that it agreed to MICROS Systems Inc. (NASDAQ:MCRS), which is a provider of information technology solutions for the hospitality and retail industries, and has a market cap of $5.07 billion. Under the terms of the agreement, MICROS stockholders will receive $68.00 in cash for each share of common stock they hold. The purchase price represents a fully-diluted equity value of about $5.3 billion, or $4.6 billion net of cash. The deal is expected to close in the second half of 2014. Aside from Havens Advisors, Robert Joseph Caruso’s Select Equity Group holds 3.42 million shares, and Jeffrey Ubben’s Valueact Capital owns 2.27 million shares of the company, according to our record.

Disclosure: none

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!